GlassScriptPhysician profile
Elizabeth Sutton
NPI 1912358490
$1,044.02
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2022: $237 · 2023: $236 · 2024: $115 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.98 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $367.80 | 2021-2023 | Botox, Skyrizi |
| Genzyme Corporation | $178.01 | 2021-2022 | |
| Lilly USA, LLC | $138.65 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $125.32 | 2022 | |
| Amgen INC. | $38.06 | 2024-2025 | Otezla |
| Galderma Laboratories, L.P. | $30.64 | 2024 | |
| Janssen Biotech, INC. | $27.23 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $20.98 | 2024 | Dupixent |
| Janssen Scientific Affairs, LLC | $17.99 | 2022 | |
| Arcutis Biotherapeutics, INC. | $17.73 | 2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.89 | 2023 | Arazlo, Jublia, Duobrii |
| Pfizer INC. | $15.27 | 2023 | |
| Incyte Corporation | $14.55 | 2022 | |
| Ucb, INC. | $14.19 | 2024 | Bimzelx |
| Leo Pharma INC. | $13.72 | 2025 | Adbry |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $6.99 | 2025 | Vtama |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.